Suchergebnisse - "Hanauer, Stephen B"

PubPharm (44)

1

Baseline TREM-1 Whole Blood Gene Expression Does Not Predict Response to Adalimumab Treatment in Patients with Ulcerative Colitis or Crohn's Disease in the SERENE Studies

enthalten in: Journal of Crohn's & colitis | 2024

von Verstockt, B. | Pivorunas, V. | Al Mahi, N. | +10

2

Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease : a multicentre, randomised, double-blind, parallel-group, phase 3b trial

enthalten in: Lancet (London, England) | 2022

von Sands, B. | Irving, P. | Hoops, T. | +117

CommentIn: Lancet. 2022 Jun 11;399(10342):2169-2171. - PMID 35691307

3

Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies : Randomized SERENE CD Trial Results

enthalten in: Gastroenterology | 2022

von D'Haens, G. | Sandborn, W. | Loftus, E. | +19

CommentIn: Gastroenterology. 2022 Jun;162(7):1831-1832. - PMID 35364063

4

Five-Year Efficacy and Safety of Ustekinumab Treatment in Crohn's Disease : The IM-UNITI Trial

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2022

von Sandborn, W. | Rebuck, R. | Wang, Y. | +11

5

Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis

enthalten in: The New England journal of medicine | 2021

von Sandborn, W. | Feagan, B. | D'Haens, G. | +114

CommentIn: Gastroenterology. 2022 May;162(6):1767-1769. - PMID 34896116

6

IM-UNITI : Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease

enthalten in: Journal of Crohn's & colitis | 2020

von Hanauer, S. | Sandborn, W. | Feagan, B. | +10

CommentIn: J Crohns Colitis. 2020 Jan 1;14(1):1-3. - PMID 31605526

7

Combination Therapy With Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy : A Post Hoc Analysis

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2019

von Colombel, J. | Adedokun, O. | Gasink, C. | +7

8

Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease

enthalten in: The New England journal of medicine | 2016

von Feagan, B. | Sandborn, W. | Gasink, C. | +125

CommentIn: Nat Rev Gastroenterol Hepatol. 2017 Jan;14(1):4. - PMID 27965515

9

Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection

enthalten in: Gastroenterology | 2016

von Regueiro, M. | Feagan, B. | Zou, B. | +115

CommentIn: Gastroenterology. 2016 Jun;150(7):1521-1524. - PMID 27138979

10

Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis

enthalten in: The New England journal of medicine | 2016

von Sandborn, W. | Feagan, B. | Wolf, D. | +111

CommentIn: N Engl J Med. 2016 Aug 25;375(8):e17. - PMID 27557326

1
2
3
4
5
Nächster »
[5]